Donepezil transdermal patch - Corium International

Drug Profile

Donepezil transdermal patch - Corium International

Alternative Names: Corplex™ donepezil transdermal patch; Donepezil transdermal patch

Latest Information Update: 07 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Corium International
  • Class Antidementias; Indans; Nootropics; Piperidines; Small molecules
  • Mechanism of Action Acetylcholinesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Alzheimer's disease

Most Recent Events

  • 07 Aug 2017 Corium International initiates a pivotal bioequivalence trial for Alzheimer's disease (In healthy volunteers) in USA
  • 20 Mar 2017 Interim results from a phase-I clinical trial in Alzheimer's disease reported by Corium
  • 21 Nov 2016 Corium International completes enrolment in its phase I trial in Healthy volunteers in US (NCT02968719)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top